Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Rhea-AI Summary

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company, has announced the release date for its second quarter 2024 financial results. The company will disclose its earnings on Thursday, August 8, 2024, after the market closes. Following the release, Co-Diagnostics will host a conference call and webcast at 4:30 p.m. ET to discuss the results with analysts and institutional investors.

The call will feature key management figures, including CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. Interested parties can access the webcast through the company's investor relations website or join the conference call using the provided domestic and international phone numbers. For those unable to attend live, a recording will be made available on the company's website later.

SALT LAKE CITY, July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2024 results on Thursday, August 8, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: ir.codiagnostics.com on the Events & Webcasts page

Conference Call: 844-481-2661 (domestic) or 412-317-0652 (international)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-second-quarter-2024-earnings-release-date-and-webcast-302206409.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics (CODX) release its Q2 2024 earnings?

Co-Diagnostics (CODX) will release its second quarter 2024 earnings on Thursday, August 8, 2024, after the market close.

How can I access Co-Diagnostics' (CODX) Q2 2024 earnings call?

You can access Co-Diagnostics' Q2 2024 earnings call via webcast at ir.codiagnostics.com or by phone at 844-481-2661 (domestic) or 412-317-0652 (international) on August 8, 2024, at 4:30 p.m. ET.

Who will be participating in Co-Diagnostics' (CODX) Q2 2024 earnings call?

The earnings call will feature CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson from Co-Diagnostics (CODX).

What if I miss Co-Diagnostics' (CODX) live Q2 2024 earnings webcast?

If you miss the live webcast, a recording of Co-Diagnostics' (CODX) Q2 2024 earnings call will be made available on the company's website later.